Price Ben Gil (CIK 0001417915)

Latest company ownership

Shares held
42,830
Last filed at
Mar 16, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2010Q2 2025Q4
IRD - Opus Genetics, Inc.
Role: Director
Shares held
3,537
Last filed at
Jun 7, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 29, 2019 Jan 31, 2019 Opus Genetics, Inc. Director Buy 90.0 +15,000 100.00% ✗ $9.1K
Mar 14, 2016 Mar 16, 2016 Sarepta Therapeutics, Inc. Director Buy 95.0 +4,500 11.74% ✗ $75.1K
Aug 19, 2013 Aug 20, 2013 Sarepta Therapeutics, Inc. Director Buy 78.8 +500 1.44% ✗ $15.6K
Mar 14, 2012 Mar 15, 2012 Sarepta Therapeutics, Inc. Director Buy 91.3 +30,000 17.86% ✗ $38.9K
Apr 6, 2011 Apr 6, 2011 Sarepta Therapeutics, Inc. Director Buy 91.3 +20,000 13.99% ✗ $30K
Aug 13, 2010 Aug 16, 2010 Sarepta Therapeutics, Inc. Director Buy 82.5 +4,000 4.04% ✗ $7.7K
Jun 11, 2010 Jun 11, 2010 Sarepta Therapeutics, Inc. Director Buy 86.3 +7,000 7.61% ✗ $10.1K
May 13, 2010 May 13, 2010 Sarepta Therapeutics, Inc. Director Buy 95.0 +40,000 45.99% ✗ $54.4K